Hormonal Contraception | Adverse Effects of Hormonal contraception |

Contraceptive counseling

 Jun 10, 2010 Viewed: 3750

Therapy selection should be individualized and based on the patient’s specific needs and global related health risks. Clearly,for the management of these cases and the individual risk evaluation, specific competence is necessary about each particular pathologic entity and the possible contraceptive action.

In fact,  the superficial evaluation can lead to refuse a safe contraceptive method when suitable, or to prescribe a hormonal contraceptive when hazardous. Adherence and continuation are fundamentally important to the successful use of hormonal contraception (43,44).

Adverse Effects of Hormonal contraception

Expert and accurate counselling can help women to achieve adequate informations, choosing the contraceptive method corresponding to their expectations. We   believe   that   this   patient   procedure   might   motivate   more consistent contraceptive taking and encourage its regular use (12,14).

—
Rosa Sabatini and Raffele Cagiano
Department of Obstetrics and Gynecology
Department of Pharmacology General Hospital Policlinico-University of Bari, Italy
—

REFERENCES

  1.   Lopez L.M., Steiner M.J., Grimes D.A., Schulz K.F. (2008). Strategies for communicating contraceptive effectiveness. Cochrane Database Syst. Rev,2, CD006964.
  2. Tafelski T., Boehm K.E. (1995). Contraception   in   the   adolescent patient. Prim. Care, 22(1), 145-59.
  3. Saeed G.A., Fakhar S., Rahim F., Tabassum S. (2008). Change in trend of contraceptive   uptake-effect   of   educational   leaflets   and   counselling. Contraception, 77(5), 377-81.
  4. Dominguez C.E. (2007).  Patient   counseling   women   using   oral contraceptives. Manag. Care Interface, 20(6), 33-7.
  5. Moreau C., Cleland K., Trussel J.  (2007). Contraceptive discontinuation attribuited to method dissatisfaction in the United States. Contraception, 76(4), 267-72.
  6. Freeman S. (2004).  Nondaily hormonal contraception:  considerations in contraceptive choice and patient counseling. J.Am. Acad. Nurse Pract, 16(6), 226-38
  7. Nelson,  A.L.  (2007).  Communicating with patients about extended-cycle and continuous use of oral contraceptives. J. Womens Health,16(4), 463-70. 
  8. Hitchcock C.L., Prior J.C. (2004). Evidence about extending the duration of oral   contraceptive   use   to   suppress   menstruation.  Women   Health Issues, 14(6), 201-11.
  9. Edelman A.B., Gallo M.F., Jensen J.T., Nichols M.D., Schulz K.F., Grimes D.A. (2005). Continuous or extended cycle vs.cyclic use of combined oral contraceptives for contraception.  Cochrane Database Syst. Rev, 20(3), CD004695
  10.   Santelli J.S.,Morrow B.,  Anderson J.E., Lindberg L.D.  (2006). Contraceptive use and pregnancy among U.S.  high school students, 1991-2003. Pespect. Sex Reprod. Health, 38, 106-11.
  11.   Anderson J.E.,  Santelli J.S., Morrow B. (2006). Trends in adolescent contraceptive use: unprotected and poorly protected sex, 1991-2003. J. Adolesc. Health, 38, 734-9. 
  12.   Rove C., Perlmutter   Silverman P., Krauss B. (2007). A   brief, low-cost, theory-based intervention to promote dual method use by black and Latina female adolescents:a randomized clinical trial. Health Educ. Behav, 34(4), 608-21. 
  13.   Ornstein R.M., Fisher M.M. (2006). Hormonal   contraception   in adolescents: special considerations. Paediatr. Drugs, 8(1), 25-45. 
  14.   Sabatini R., Orsini,  G., Cagiano,  R.,  Loverro,  G.  (2007).  Noncontraceptive benefits of two combined oral contraceptives with antiandrogenic properties among adolescents. Contraception,76, 342-347. 
  15.   Prabhakaran S. (2008). Self-administration of injectable contraceptives. Contraception, 77 (5), 315-7. 
  16.   Kailas N.A., Sifakis S., Koumantakis E.  (2005). Contraception   durin perimenopause. Eur. J. Contracept Reprod. Health Care, 10(1), 19-25. 
  17.   Bathema R. K., Guillebaud J. (2006). Contraception for the older woman: an up date. Climacteric, 9(4), 264-76.
  18.   Thorneycroft I.H.  (1993). Contraception in women older than 40 years of age. Obstet. Gynecol. Clin. North. Am, 20(2), 273-8
  19.   Shaaban M.M. (1996). The perimenopause and contraception. Maturitas, 23(2), 181-92.
  20.   Speroff L, Sulak PJ. (1995). Contraception in the later reproductive years: a valid aspect of preventive health care. Dialogues Contracept, 4(5), 1-4
  21.   Fasubaa O.B., Ojo O.D. (2004). Impact of post-abortion counselling in a semi-urban town of Western Nigeria. J. 0bstet. Gynaecol, 24(3), 298-303.
  22.   Engin-Ustun Y., Ustun Y., Cetin F., Meydanli M.M., Kafkasli A., Sezgin B.  (2007).  Effect of postpartum counseling on postpartum contraceptive use. Arch. Gynecol. Obstet,275(6), 429-32.
  23.   Bulut, A., Turan, J.M. (1995). Postpartum family planning and health needs of women of low income in Istambul. Stud. Fam. Plann, 26(2), 88-100.
  24.   Nunez-Urquiza R.M., Hernandez-Prado B., Garcia-Barrios C., Gonzalez D., Walker D.  (2003).  Unwanted adolescent pregnancy and post-partum utilization of contraceptive methods. Salud. Publica Mex, 45(1), S 92-102.
  25.   Kjos S.L. (2007). After pregnancy complicated by diabetes: postpartum care and education. Obstet. Gynecol. Clin. North Am, 34(2), 335-49.
  26.   De   Villiers   E.M.  (2003). Relationship between steroid hormone contraceptives and HPV,  cervical intraepithelial neoplasia and cervical carcinoma. Int. J. Cancer, 103(6), 70
  27.   Moodley M., Moodley J., Chetty R., Herrington C.S.  (2003). The role of steroid contraceptive hormones in the pathogenesis of invasive cervical cancer: a review. Int. J. Gynecol. Cancer,13(2), 103-10
  28.   Green J., Berrington deGonzales A., Smith J.S., Mfranceschi S., Appleby P., Plummer M.,  Beral V.  (2003). Human papillomavirus and use of oral contraceptives. Br. J. Cancer, 88(11), 1713-20.
  29.   Aaron E., Levine,  A.B.  (2005). Gynecologic care and family planning for HIV-infected women. AIDS Read, 15(8), 420-3, 426-8. 
  30.   Delvaux T., Noslinger C. (2007). Reproductive choice for women and men living   with   HIV:  contraception,  abortion   and   fertility. Reprod. Health Matters, 15 (29 Suppl.), 46-66. 
  31.   Mitchell H.S., Stephens E. (2004). Contraception choice for HIV positive women. Sex. Transm. Infect, 80(3), 167-73. 
  32.   Yassin A.S., Cordwell D. (2005).  Does   dedicated   pre-abortion contraception counselling help to improve post-abortion contraception uptake? J.Fam. Plann. Reprod. HealthCare, 31(2), 115-6. 
  33.   El-Tagy   A., Sakr E., Sokal D.C., Issa A.H. (2003).  Safety   and acceptability   of   post-abrtal   IUD   insertion   and   the   importance   of counselling. Contraception, 67(3),229-34. 
  34.   Klinke J., Toth E.L.  (2003).  Preconception care for women with type 1 diabetes. Can.Fam.Physician, 49,769-73. 
  35.   Charron-Prochownik D., Sereika S.M., Wang S.L., Hannan M.F., Fischi A.R., Stewart S.H., Dean – McElhinny, T. (2006). Reproductive health and preconception counseling awareness in adolescents with diabetes: what they don’t know can hurt them. Diabetes Educ, 32(2),235-42.
  36.   Charron-Prochownik   D.,  Ferons-Hannan   M., Sereika S., Becker,  D. (2008). Randomize Efficacy Trial of Early Preconception Counseling FOE Diabetic Teens (READY –Girls ) Diabetes Care, Apr.  14.(Epub.  Ahead of print).
  37.   Teal S.B., Ginosar D.M.  (2007). Contraception for women with chronic medical conditions. Obstet.Gynecol.Clin.North Am, 34(1),113-26. 
  38.   Shilling M.K., Zimmermann A., Radaelli C., Seiler C.A., Buchler M.W. (2000). Liver nodules resembling focal nodular hyperplasia after hepatic venous thrombosis. J.Hepatol,33(4),673-6.
  39.   Shortell C.K.,  Schwartz.  S.I.  (1991).  Hepatic adenoma and focal nodular hyperplasia. Surg. Gynecol. Obstet, 173(5), 426-31. 
  40.   Lakasing L., Khamashta M. (2001). Contraceptive practices in women with systemic lupus erythematous and/or antiphospholipid syndrome: what advice should we be giving? J.Fam. Plann. Reprod. Health Care, 27(1), 7-12
  41.   Seifert-Klauss V.,  Kaemmerer H.,  Brunner B.,  Schneider K. T., Hess J. (2000). Contraception in patients with congenital heart defects. Z.Kardiol,89(7), 606-11. 
  42.   Rongieres-Bertrand C.,  Fernandez H.  (1998). Contraceptive use in female transplant recipients. Contracept. Fertil. Sex, 26(2), 845-50. 
  43.   Dominguez C.E. (2007).  Patient counseling   women   using   oral contraceptives. Manag. Care Interface, 20(6), 33-7.
  44.   Halpern V., Grimes D.A., Lopez L., Gallo M.F. (2006). Strategies   to improve adherence acceptability of hormonal methods for contraception. Cochrane Database Syst. Rev,25(1), CD004317.

Page 3 of 31 2 3

Provided by ArmMed Media